COI Pharmaceuticals Gets $576M Exit
socalTECH
NOVEMBER 13, 2019
San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.
Let's personalize your content